MDMB™ is a new drug class that combines the antipsychotic efficacy of atypical agents with the mood-stabilizing efficacy of lithium without inducing serious metabolic side effects.
PINACA (pyrrolidin catheters acetate) is a synthetic cannabinoid that acts as a partial agonist at both the CB1 and CB2 receptors, with a Ki of 41.4 nM for CB1 and 1.7 nM for CB2.
MDMB™ is a new drug class that combines the antipsychotic efficacy of atypical agents with the mood-stabilizing efficacy of lithium without inducing serious metabolic side effects.
PINACA (pyrrolidin catheters acetate) is a synthetic cannabinoid that acts as a partial agonist at both the CB1 and CB2 receptors, with a Ki of 41.4 nM for CB1 and 1.7 nM for CB2.
